Quiz for Clinicians
Reviewed by: HU Medical Review Board | Last reviewed: May 2026 | Last updated: June 2026
Psoriatic arthritis is far more than a simple "skin and joint" condition – it is a heterogeneous, multi-domain systemic inflammatory disorder that requires a nuanced, evidence-based approach to management. These conceptual questions will test your ability to navigate complex clinical scenarios beyond standard textbook definitions.
Clinical Challenge
A 42-year-old male with a history of plaque psoriasis presents with asymmetric oligoarthritis affecting the distal interphalangeal (DIP) joints and a current swollen, painful 'sausage' second toe. Laboratory workup reveals a weakly positive rheumatoid factor (RF) at a low titer, but anti-CCP is negative. Plain radiographs demonstrate juxta-articular new bone formation in the affected foot. According to the Classification Criteria for Psoriatic Arthritis (CASPAR), how many points does this patient score, and is the diagnosis of PsA confirmed?
Clinical Challenge
A 35-year-old female with confirmed PsA presents with severe, active enthesitis at the Achilles insertion and significant inflammatory back pain indicative of axial involvement. She has had an inadequate response to maximum-dose NSAID therapy over the past 3 months. According to current GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) guidelines, which of the following is the most appropriate next step in her therapeutic management?
Clinical Challenge
A 48-year-old patient with active peripheral PsA and concomitant severe plaque psoriasis (covering 12 percent of body surface area) has experienced a secondary loss of efficacy to their first TNF inhibitor (adalimumab) after 18 months of treatment. The patient strongly prefers transitioning to an oral medication but expresses concern over the routine laboratory monitoring (e.g., lipids, CBC) and safety profile associated with traditional JAK 1/3 inhibitors. Which of the following is most appropriate to optimize both robust cutaneous clearance and musculoskeletal control while aligning with the patient's preferences?
Clinical Challenge
Beyond musculoskeletal and cutaneous manifestations, PsA is recognized as a profound systemic inflammatory disorder. Which statement accurately reflects the clinical and epidemiological reality of cardiovascular comorbidity in patients with PsA?
Clinical Challenge
Genetic susceptibility plays a critical role in shaping the clinical heterogeneity of psoriatic disease. Which human leukocyte antigen (HLA) allele is most strongly associated with the specific phenotype of axial involvement and an earlier age of disease onset in patients with PsA?